List of Tables
Table 1. COVID-19 Drugs Market Trends
Table 2. COVID-19 Drugs Market Drivers & Opportunity
Table 3. COVID-19 Drugs Market Challenges
Table 4. COVID-19 Drugs Market Restraints
Table 5. Global COVID-19 Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global COVID-19 Drugs Revenue Market Share by Company (2019-2024)
Table 7. Key Companies COVID-19 Drugs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies COVID-19 Drugs Product Type
Table 9. Key Companies Time to Begin Mass Production of COVID-19 Drugs
Table 10. Global COVID-19 Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Drugs as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global COVID-19 Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global COVID-19 Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global COVID-19 Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global COVID-19 Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global COVID-19 Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global COVID-19 Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global COVID-19 Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global COVID-19 Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global COVID-19 Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global COVID-19 Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global COVID-19 Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global COVID-19 Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global COVID-19 Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global COVID-19 Drugs Sales Value by Region (2019-2024) & (%)
Table 27. Global COVID-19 Drugs Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions COVID-19 Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions COVID-19 Drugs Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions COVID-19 Drugs Sales Value, (2025-2030) & (US$ Million)
Table 31. Sanofi Basic Information List
Table 32. Sanofi Description and Business Overview
Table 33. Sanofi COVID-19 Drugs Products, Services and Solutions
Table 34. Revenue (US$ Million) in COVID-19 Drugs Business of Sanofi (2019-2024)
Table 35. Sanofi Recent Developments
Table 36. Novartis Basic Information List
Table 37. Novartis Description and Business Overview
Table 38. Novartis COVID-19 Drugs Products, Services and Solutions
Table 39. Revenue (US$ Million) in COVID-19 Drugs Business of Novartis (2019-2024)
Table 40. Novartis Recent Developments
Table 41. Shanghai Zhongxisanwei Basic Information List
Table 42. Shanghai Zhongxisanwei Description and Business Overview
Table 43. Shanghai Zhongxisanwei COVID-19 Drugs Products, Services and Solutions
Table 44. Revenue (US$ Million) in COVID-19 Drugs Business of Shanghai Zhongxisanwei (2019-2024)
Table 45. Shanghai Zhongxisanwei Recent Developments
Table 46. Teva Basic Information List
Table 47. Teva Description and Business Overview
Table 48. Teva COVID-19 Drugs Products, Services and Solutions
Table 49. Revenue (US$ Million) in COVID-19 Drugs Business of Teva (2019-2024)
Table 50. Teva Recent Developments
Table 51. Zydus Cadila Basic Information List
Table 52. Zydus Cadila Description and Business Overview
Table 53. Zydus Cadila COVID-19 Drugs Products, Services and Solutions
Table 54. Revenue (US$ Million) in COVID-19 Drugs Business of Zydus Cadila (2019-2024)
Table 55. Zydus Cadila Recent Developments
Table 56. Mylan Basic Information List
Table 57. Mylan Description and Business Overview
Table 58. Mylan COVID-19 Drugs Products, Services and Solutions
Table 59. Revenue (US$ Million) in COVID-19 Drugs Business of Mylan (2019-2024)
Table 60. Mylan Recent Developments
Table 61. Apotex Basic Information List
Table 62. Apotex Description and Business Overview
Table 63. Apotex COVID-19 Drugs Products, Services and Solutions
Table 64. Revenue (US$ Million) in COVID-19 Drugs Business of Apotex (2019-2024)
Table 65. Apotex Recent Developments
Table 66. Advanz Pharma Basic Information List
Table 67. Advanz Pharma Description and Business Overview
Table 68. Advanz Pharma COVID-19 Drugs Products, Services and Solutions
Table 69. Revenue (US$ Million) in COVID-19 Drugs Business of Advanz Pharma (2019-2024)
Table 70. Advanz Pharma Recent Developments
Table 71. Sun Pharma Basic Information List
Table 72. Sun Pharma Description and Business Overview
Table 73. Sun Pharma COVID-19 Drugs Products, Services and Solutions
Table 74. Revenue (US$ Million) in COVID-19 Drugs Business of Sun Pharma (2019-2024)
Table 75. Sun Pharma Recent Developments
Table 76. Kyung Poong Basic Information List
Table 77. Kyung Poong Description and Business Overview
Table 78. Kyung Poong COVID-19 Drugs Products, Services and Solutions
Table 79. Revenue (US$ Million) in COVID-19 Drugs Business of Kyung Poong (2019-2024)
Table 80. Kyung Poong Recent Developments
Table 81. Ipca Laboratories Basic Information List
Table 82. Ipca Laboratories Description and Business Overview
Table 83. Ipca Laboratories COVID-19 Drugs Products, Services and Solutions
Table 84. Revenue (US$ Million) in COVID-19 Drugs Business of Ipca Laboratories (2019-2024)
Table 85. Ipca Laboratories Recent Developments
Table 86. Hanlim Pharmaceutical Basic Information List
Table 87. Hanlim Pharmaceutical Description and Business Overview
Table 88. Hanlim Pharmaceutical COVID-19 Drugs Products, Services and Solutions
Table 89. Revenue (US$ Million) in COVID-19 Drugs Business of Hanlim Pharmaceutical (2019-2024)
Table 90. Hanlim Pharmaceutical Recent Developments
Table 91. Bristol Laboratories Basic Information List
Table 92. Bristol Laboratories Description and Business Overview
Table 93. Bristol Laboratories COVID-19 Drugs Products, Services and Solutions
Table 94. Revenue (US$ Million) in COVID-19 Drugs Business of Bristol Laboratories (2019-2024)
Table 95. Bristol Laboratories Recent Developments
Table 96. Bayer Basic Information List
Table 97. Bayer Description and Business Overview
Table 98. Bayer COVID-19 Drugs Products, Services and Solutions
Table 99. Revenue (US$ Million) in COVID-19 Drugs Business of Bayer (2019-2024)
Table 100. Bayer Recent Developments
Table 101. Rising Pharmaceutical Basic Information List
Table 102. Rising Pharmaceutical Description and Business Overview
Table 103. Rising Pharmaceutical COVID-19 Drugs Products, Services and Solutions
Table 104. Revenue (US$ Million) in COVID-19 Drugs Business of Rising Pharmaceutical (2019-2024)
Table 105. Rising Pharmaceutical Recent Developments
Table 106. Shanghai Pharma Basic Information List
Table 107. Shanghai Pharma Description and Business Overview
Table 108. Shanghai Pharma COVID-19 Drugs Products, Services and Solutions
Table 109. Revenue (US$ Million) in COVID-19 Drugs Business of Shanghai Pharma (2019-2024)
Table 110. Shanghai Pharma Recent Developments
Table 111. Sichuan Sunny Hope Basic Information List
Table 112. Sichuan Sunny Hope Description and Business Overview
Table 113. Sichuan Sunny Hope COVID-19 Drugs Products, Services and Solutions
Table 114. Revenue (US$ Million) in COVID-19 Drugs Business of Sichuan Sunny Hope (2019-2024)
Table 115. Sichuan Sunny Hope Recent Developments
Table 116. Guangzhou Baiyunshan Guanghua Pharmaceutical Basic Information List
Table 117. Guangzhou Baiyunshan Guanghua Pharmaceutical Description and Business Overview
Table 118. Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs Products, Services and Solutions
Table 119. Revenue (US$ Million) in COVID-19 Drugs Business of Guangzhou Baiyunshan Guanghua Pharmaceutical (2019-2024)
Table 120. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments
Table 121. CSPC Group Basic Information List
Table 122. CSPC Group Description and Business Overview
Table 123. CSPC Group COVID-19 Drugs Products, Services and Solutions
Table 124. Revenue (US$ Million) in COVID-19 Drugs Business of CSPC Group (2019-2024)
Table 125. CSPC Group Recent Developments
Table 126. KPC Group Basic Information List
Table 127. KPC Group Description and Business Overview
Table 128. KPC Group COVID-19 Drugs Products, Services and Solutions
Table 129. Revenue (US$ Million) in COVID-19 Drugs Business of KPC Group (2019-2024)
Table 130. KPC Group Recent Developments
Table 131. Jinghua Pharmaceutical Group Basic Information List
Table 132. Jinghua Pharmaceutical Group Description and Business Overview
Table 133. Jinghua Pharmaceutical Group COVID-19 Drugs Products, Services and Solutions
Table 134. Revenue (US$ Million) in COVID-19 Drugs Business of Jinghua Pharmaceutical Group (2019-2024)
Table 135. Jinghua Pharmaceutical Group Recent Developments
Table 136. Zhongsheng Pharma Basic Information List
Table 137. Zhongsheng Pharma Description and Business Overview
Table 138. Zhongsheng Pharma COVID-19 Drugs Products, Services and Solutions
Table 139. Revenue (US$ Million) in COVID-19 Drugs Business of Zhongsheng Pharma (2019-2024)
Table 140. Zhongsheng Pharma Recent Developments
Table 141. North China Pharmaceutical Group Basic Information List
Table 142. North China Pharmaceutical Group Description and Business Overview
Table 143. North China Pharmaceutical Group COVID-19 Drugs Products, Services and Solutions
Table 144. Revenue (US$ Million) in COVID-19 Drugs Business of North China Pharmaceutical Group (2019-2024)
Table 145. North China Pharmaceutical Group Recent Developments
Table 146. Key Raw Materials Lists
Table 147. Raw Materials Key Suppliers Lists
Table 148. COVID-19 Drugs Downstream Customers
Table 149. COVID-19 Drugs Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
Table 153. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. COVID-19 Drugs Product Picture
Figure 2. Global COVID-19 Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global COVID-19 Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. COVID-19 Drugs Report Years Considered
Figure 5. Global COVID-19 Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by COVID-19 Drugs Revenue in 2023
Figure 7. COVID-19 Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Tablet Picture
Figure 9. Injection Picture
Figure 10. Global COVID-19 Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global COVID-19 Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Mild Symptom Patient
Figure 13. Product Picture of Critically Ill Patient
Figure 14. Global COVID-19 Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global COVID-19 Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 16. North America COVID-19 Drugs Sales Value (2019-2030) & (US$ Million)
Figure 17. North America COVID-19 Drugs Sales Value by Country (%), 2023 VS 2030
Figure 18. Europe COVID-19 Drugs Sales Value (2019-2030) & (US$ Million)
Figure 19. Europe COVID-19 Drugs Sales Value by Country (%), 2023 VS 2030
Figure 20. Asia Pacific COVID-19 Drugs Sales Value (2019-2030) & (US$ Million)
Figure 21. Asia Pacific COVID-19 Drugs Sales Value by Country (%), 2023 VS 2030
Figure 22. South America COVID-19 Drugs Sales Value (2019-2030) & (US$ Million)
Figure 23. South America COVID-19 Drugs Sales Value by Country (%), 2023 VS 2030
Figure 24. Middle East & Africa COVID-19 Drugs Sales Value (2019-2030) & (US$ Million)
Figure 25. Middle East & Africa COVID-19 Drugs Sales Value by Country (%), 2023 VS 2030
Figure 26. Key Countries/Regions COVID-19 Drugs Sales Value (%), (2019-2030)
Figure 27. United States COVID-19 Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 28. United States COVID-19 Drugs Sales Value by Type (%), 2023 VS 2030
Figure 29. United States COVID-19 Drugs Sales Value by Application (%), 2023 VS 2030
Figure 30. Europe COVID-19 Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 31. Europe COVID-19 Drugs Sales Value by Type (%), 2023 VS 2030
Figure 32. Europe COVID-19 Drugs Sales Value by Application (%), 2023 VS 2030
Figure 33. China COVID-19 Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 34. China COVID-19 Drugs Sales Value by Type (%), 2023 VS 2030
Figure 35. China COVID-19 Drugs Sales Value by Application (%), 2023 VS 2030
Figure 36. Japan COVID-19 Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 37. Japan COVID-19 Drugs Sales Value by Type (%), 2023 VS 2030
Figure 38. Japan COVID-19 Drugs Sales Value by Application (%), 2023 VS 2030
Figure 39. South Korea COVID-19 Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 40. South Korea COVID-19 Drugs Sales Value by Type (%), 2023 VS 2030
Figure 41. South Korea COVID-19 Drugs Sales Value by Application (%), 2023 VS 2030
Figure 42. Southeast Asia COVID-19 Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 43. Southeast Asia COVID-19 Drugs Sales Value by Type (%), 2023 VS 2030
Figure 44. Southeast Asia COVID-19 Drugs Sales Value by Application (%), 2023 VS 2030
Figure 45. India COVID-19 Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 46. India COVID-19 Drugs Sales Value by Type (%), 2023 VS 2030
Figure 47. India COVID-19 Drugs Sales Value by Application (%), 2023 VS 2030
Figure 48. COVID-19 Drugs Industrial Chain
Figure 49. COVID-19 Drugs Manufacturing Cost Structure
Figure 50. Channels of Distribution (Direct Sales, and Distribution)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
